Evidence map›Paper›PMID 34646417›Full record

ArticleInternational journal of clinical and experimental pathology2021

Hilar cholangiocarcinoma with extensive immunoglobulin G4 reaction.

Minako Yamamura, Yasunori Sato, Kenta Takahashi, Hiep Nguyen Canh, Zihan Li, Tatsuya Kimoto, Shuichi Terasaki, Kenichi Harada

Open access · greenAbstract readCase Reports
In one paragraph

Article in International journal of clinical and experimental pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 80% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Minako YamamuraDepartment of Human Pathology, Kanazawa University Graduate School of Medicine Kanazawa, Japan.
Yasunori SatoDepartment of Human Pathology, Kanazawa University Graduate School of Medicine Kanazawa, Japan.
Kenta TakahashiDepartment of Human Pathology, Kanazawa University Graduate School of Medicine Kanazawa, Japan.
Hiep Nguyen CanhDepartment of Human Pathology, Kanazawa University Graduate School of Medicine Kanazawa, Japan.
Zihan LiDepartment of Human Pathology, Kanazawa University Graduate School of Medicine Kanazawa, Japan.
Tatsuya KimotoDepartment of Radiology, Japan Red Cross Kanazawa Hospital Kanazawa, Japan.
Shuichi TerasakiDepartment of Gastroenterology, Japan Red Cross Kanazawa Hospital Kanazawa, Japan.
Kenichi HaradaDepartment of Human Pathology, Kanazawa University Graduate School of Medicine Kanazawa, Japan.
Kanazawa University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunoglobulin G4 (IgG4)-related disease (IgG4-RD) is a systemic fibroinflammatory disorder that can involve multiple organs. It is often challenging to distinguish IgG4-related sclerosing cholangitis (IgG4-SC) from cholangiocarcinoma because of overlap in their clinical findings. A 75-year-old man presented to a hospital for a detailed examination of the elevation of some biliary enzymes. Radiographic examination revealed segmental bile duct with wall thickening of the common hepatic bile duct, and dilation of the peripheral branches. Transampullary biopsy showed a non-specific inflammatory reaction with several IgG4-positive cell infiltrations. There were no signs of malignancy. The liver biopsy showed bile duct injury accompanied by IgG4-positive cell infiltration. We then performed bile duct biopsy and finally diagnosed the patient with cholangiocarcinoma. We should remember that the IgG4 reaction is neither completely sensitive nor specific for IgG4-RD and avoid resting solely on the IgG4 reaction to precisely distinguish IgG4-SC from cholangiocarcinoma.

Indexed as

CholangiocarcinomaIgG4-related sclerosing cholangitisimmunoglobulin G4 (IgG4) IgG4-related diseaseimmunoglobulin G4 (IgG4) reaction

Identifiers

PMID34646417
PMCPMC8493266
OpenAlexW3205527436

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.